c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

BACKGROUND: KIT inhibitors, such as toceranib (TOC), and vinblastine (VBL) have not been prospectively compared in the treatment of macroscopic mast cell tumors (MCTs). Also, it is unknown whether VBL or TOC is superior for treating MCT without c‐kit mutations. HYPOTHESIS/OBJECTIVES: To determine th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Vet Intern Med
Hlavní autoři: Weishaar, K.M., Ehrhart, E.J., Avery, A.C., Charles, J.B., Elmslie, R.E., Vail, D.M., London, C.A., Clifford, C.A., Eickhoff, J.C., Thamm, D.H.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
SMALL ANIMAL
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5787208/
https://ncbi.nlm.nih.gov/pubmed/29194765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.14889
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky